Noboru Harada

Noboru Harada

Auto-generated profile, based on publicly available information

Noboru Harada

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
KYKyohei Yugawa
Kyohei Yugawa
Tomoharu YoshizumiTomoharu Yoshizumi
Tomoharu Yoshizumi
YMYohei Mano
Yohei Mano
SIShinji Itoh
Shinji Itoh
NHNoboru Harada
Noboru Harada
MMMasaki Mori
Masaki Mori

15 January 2008 in Transplantation
Verified
Journal Article
Closed access
NHNoboru Harada
Noboru Harada
YSYuji Soejima
Yuji Soejima
ATAkinobu Taketomi
Akinobu Taketomi
TYTomoharu Yoshizumi
Tomoharu Yoshizumi
TIToru Ikegami
Toru Ikegami
YMYoshihiko Maehara
Yoshihiko Maehara
Transient elastography (FibroScan) is a simple and noninvasive method to assess liver fibrosis by measuring liver stiffness and therefore can be a promising tool to evaluate liver fibrosis and avoid liver biopsy. We prospectively assessed the performance of transient elastography in patients with recurrent hepatitis C virus after living donor liver transplantation, in comparison with the surrogate serum markers. Fifty-six patients with recurrent hepatitis C virus after living donor liver transplantation, who underwent both liver biopsy and transient elastography were included in this study. The grade of liver fibrosis (the Scheuer classification) obtained by biopsy was compared to liver stiffness measured by the transient elastography. The fibrosis grades were as follows: F0, n=22; F1, n=13; F2, n=9; F3, n=7; and F4, n=5. Liver stiffness values ranged from 2.9 to 72.0 kPa. The optimal cutoff values were 8.8 kPa for F≥1, 9.9 kPa for F ≥2, 15.4 kPa for F≥3, and 26.5 kPa for F≥4. The area under the receiver operator characteristic curve for the diagnosis of fibrosis (F≥2) by transient elastography was 0.92, while that by hyaluronic acid, type 4 collagen, alanine aminotransferase, and the aspartate transaminase to platelets ratio index were 0.52, 0.62, 0.64, and 0.70, respectively. These data suggest that transient elastography is a simple, noninvasive and reliable tool to assess liver fibrosis in patients with recurrent hepatitis C virus after living donor liver transplantation.

1 February 2021 in Journal of Hepatology
Verified
Journal Article
Closed access
Tomoharu YoshizumiTomoharu Yoshizumi
Tomoharu Yoshizumi
SIShinji Itoh
Shinji Itoh
MSMototsugu Shimokawa
Mototsugu Shimokawa
SIShoichi Inokuchi
Shoichi Inokuchi
NHNoboru Harada
Noboru Harada
MMMasaki Mori
Masaki Mori

2 December 2014 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
NHNoboru Harada
Noboru Harada
KSKen Shirabe
Ken Shirabe
TMTakashi Maeda
Takashi Maeda
HKHiroto Kayashima
Hiroto Kayashima
TITeruyoshi Ishida
Teruyoshi Ishida
YMYoshihiko Maehara
Yoshihiko Maehara

1 December 2004 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
NHNoboru Harada
Noboru Harada
MSMitsuo Shimada
Mitsuo Shimada
SOShinji Okano
Shinji Okano
TSTaketoshi Suehiro
Taketoshi Suehiro
YSYuji Soejima
Yuji Soejima
YMYoshihiko Maehara
Yoshihiko Maehara
Immunosuppressive therapy for organ transplantation is essential for controlling rejection. When liver transplantation is performed as a therapy for hepatocellular carcinoma (HCC), recurrent HCC is one of the most fatal complications. In this study, we show that intratumoral murine IL-12 (mIL-12) gene therapy has the potential to be an effective treatment for malignancies under immunosuppression. C3H mice (H-2k), injected with FK506 (3 mg/kg) i.p., were s.c. implanted with 2.5 × 106 MH134 cells (H-2k) and we treated the established HCC with electroporation-mediated gene therapy using mIL-12 plasmid DNA. Intratumoral gene transfer of mIL-12 elevated intratumoral mIL-12, IFN-γ, and IFN-γ-inducible protein-10, significantly reduced the number of microvessels and inhibited the growth of HCC, compared with HCC-transferred control pCAGGS plasmid. The inhibition of tumor growth in immunosuppressed mice was comparable with that of mIL-12 gene therapy in immunocompetent mice. Intratumoral mIL-12 gene therapy enhanced lymphocytic infiltration into the tumor and elicited the MH134-specific CTL response even under FK506. The dose of FK506 was sufficient to prevent the rejection of distant allogenic skin grafts (BALB/c mice, H-2d) and tumors, B7-p815 (H-2d) used as transplants, during mIL-12 gene therapy against MH134. Ab-mediated depletion studies suggested that the inhibition of tumor growth, neovascularization, and spontaneous lung metastasis by mIL-12 was dependent almost entirely on NK cells and partially on T cells. These results suggest that intratumoral mIL-12 gene therapy is a potent effective strategy not only to treat recurrences of HCC in liver transplantation, but also to treat solid malignant tumors in immunosuppressed patients with transplanted organ.

1 October 2021 in Pancreatology
Verified
Journal Article
Closed access
SIShinji Itoh
Shinji Itoh
ETEiji Tsujita
Eiji Tsujita
KFKengo Fukuzawa
Kengo Fukuzawa
KSKeishi Sugimachi
Keishi Sugimachi
TITomohiri Iguchi
Tomohiri Iguchi
MMMasaki Mori
Masaki Mori